Full Text

Turn on search term navigation

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Polyisocyanopeptide (PIC) hydrogels are proposed as promising wound dressings. These gels are thermo-sensitive, allow application as a cold liquid, and rely on gelation through body heat. It is supposed that the gel can be easily removed by reversing the gelation and washing it away with a cold irrigation solution. The impact on wound healing of the regular application and removal of PIC dressings is compared to a single application of PIC and the clinically used Tegaderm™ in murine splinted full-thickness wounds for up to 14 days. SPECT/CT analysis of 111In-labelled PIC gels showed that, on average, 58% of the PIC gel could be washed out of the wounds with the employed method, which is, however, heavily influenced by personal technique. Evaluation with photography and (immuno-)histology showed that wounds in which PIC dressings were regularly removed and replaced were smaller at 14 days post-injury but performed on par with the control treatment. Moreover, the encapsulation of PIC in wound tissue was less severe and occurred less often when PIC was regularly refreshed. In addition, no morphological damage related to the removal procedure was observed. Thus, PIC gels are atraumatic and perform similarly to currently employed wound dressing materials, offering possible future benefits for both clinicians and patients.

Details

Title
Repeated Application and Removal of Polyisocyanopeptide Hydrogel Wound Dressings in a Splinted Full-Thickness Wound Model
Author
Roel C Op ‘t Veld 1 ; Joosten, Lieke 2   VIAFID ORCID Logo  ; Laverman, Peter 2 ; Bronkhorst, Ewald M 3   VIAFID ORCID Logo  ; Jansen, John A 4   VIAFID ORCID Logo  ; Walboomers, X Frank 4 ; Frank A D T G Wagener 5   VIAFID ORCID Logo 

 Department of Dentistry—Biomaterials, Research Institute for Medical Innovation, Radboud University Medical Centre, 6525 EX Nijmegen, The Netherlands; Department of Dentistry—Orthodontics and Craniofacial Biology, Research Institute for Medical Innovation, Radboud University Medical Centre, Philips van Leydenlaan 25, 6525 EX Nijmegen, The Netherlands 
 Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands 
 Department of Dentistry, Research Institute for Medical Innovation, Radboud University Medical Centre, 6525 EX Nijmegen, The Netherlands 
 Department of Dentistry—Biomaterials, Research Institute for Medical Innovation, Radboud University Medical Centre, 6525 EX Nijmegen, The Netherlands 
 Department of Dentistry—Orthodontics and Craniofacial Biology, Research Institute for Medical Innovation, Radboud University Medical Centre, Philips van Leydenlaan 25, 6525 EX Nijmegen, The Netherlands 
First page
5127
Publication year
2023
Publication date
2023
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2791658469
Copyright
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.